Health Care & Life Sciences » Pharmaceuticals | Spectrum Pharmaceuticals Inc.

Spectrum Pharmaceuticals Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
159,777.00
133,248.00
139,986.00
158,469.00
227,571.00
203,988
Total Accounts Receivable
57,022.00
76,247.00
42,956.00
45,536.00
34,393.00
33,571
Inventories
13,519.00
9,200.00
4,176.00
8,715.00
5,715.00
3,550
Other Current Assets
4,872.00
3,774.00
3,507.00
3,930.00
10,067.00
9,579
Total Current Assets
235,190.00
222,469.00
190,625.00
216,650.00
277,746.00
250,688
Net Property, Plant & Equipment
1,535.00
1,405.00
918.00
449.00
589.00
385
Total Investments and Advances
3,593.00
8,501.00
5,189.00
11,533.00
37,530.00
-
Long-Term Note Receivable
-
-
-
1,510.00
1,517.00
-
Intangible Assets
249,853.00
248,295.00
208,295.00
182,120.00
155,321.00
129,655
Other Assets
8,984.00
9,363.00
14,022.00
16,506.00
14,736.00
10,158
Total Assets
499,155.00
490,033.00
419,049.00
439,644.00
493,286.00
393,813
ST Debt & Current Portion LT Debt
-
-
-
-
38,224.00
Accounts Payable
12,796.00
8,994.00
26,684.00
30,488.00
28,548.00
Income Tax Payable
3.00
-
-
-
-
Other Current Liabilities
77,185.00
100,445.00
49,659.00
35,025.00
42,977.00
Total Current Liabilities
89,984.00
109,439.00
76,343.00
65,513.00
109,749.00
Long-Term Debt
91,480.00
96,298.00
99,377.00
97,043.00
-
Provision for Risks & Charges
-
2,441.00
2,177.00
2,053.00
6,448.00
Deferred Taxes
7,168.00
6,569.00
6,779.00
6,675.00
1,438.00
Other Liabilities
28,917.00
20,732.00
21,516.00
21,458.00
18,465.00
Total Liabilities
217,549.00
235,479.00
206,192.00
203,618.00
141,947.00
Common Equity (Total)
281,483.00
254,431.00
212,734.00
236,026.00
351,339.00
Total Shareholders' Equity
281,606.00
254,554.00
212,857.00
236,026.00
351,339.00
Total Equity
281,606.00
254,554.00
212,857.00
236,026.00
351,339.00
Liabilities & Shareholders' Equity
499,155.00
490,033.00
419,049.00
439,644.00
493,286.00
Preferred Stock (Carrying Value)
123.00
123.00
123.00
-
-

About Spectrum Pharmaceuticals

View Profile
Address
11500 South Eastern Avenue
Henderson Nevada 89052
United States
Employees -
Website http://www.sppirx.com
Updated 07/08/2019
Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development, and commercialization of pipeline of late-stage clinical and commercial products. It operates through the following brands: FOLOTYN, ZEVALIN, MARQIBO, BELEODAQ, and EVOMELA. The company was founded in December 1987 and is headquartered in Henderson, NV.